0
ARTICLE |

The Evolution of Toxic Nodular Goiter

J. MARTIN MILLER, MD; ROBERT C. HORN, MD; MELVIN A. BLOCK, MD
Arch Intern Med. 1964;113(1):72-88. doi:10.1001/archinte.1964.00280070074014.
Text Size: A A A
Published online

In 1913 Plummer differentiated exophthalmic goiter from toxic adenomatous goiter on the basis of clinical observations on 2,000 operated cases.1 He recognized that the former might be superimposed on any stage of endemic goiter, with resultant problems in differential diagnosis that might be difficult to resolve on either clinical or pathological grounds.2 That this problem is present 50 years later is clearly attested by literature relating to the treatment of hyperthyroidism with I131. In these writings the term toxic nodular goiter is often used to describe any case of hyperthyroidism occurring in a nodular gland as judged by the inclusion of patients with actual exophthalmos in this category.3,4 Other authors use it in a more restricted sense to describe only non-Graves' hyperthyroidism.5

We describe two groups of patients without clinical features of Graves' disease (exophthalmic goiter) as toxic nodular goiter: first, those with a solitary nodule

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 52

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();